INDUCIBLE IL-2 AND PD-1/PD-L1 COMBINATION THERAPY

This disclosure relates to methods and compositions for treating cancer using a combination therapy comprising an inducible IL-2 prodrug in combination with pembrolizumab.

Saved in:
Bibliographic Details
Main Authors HICKLIN, Daniel, ISAACS, Randi, SEIDEL-DUGAN, Cynthia, SALMERON-GARCIA, Jose Andres, BRODKIN, Heather, WINSTON, William
Format Patent
LanguageEnglish
Published 04.07.2024
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:This disclosure relates to methods and compositions for treating cancer using a combination therapy comprising an inducible IL-2 prodrug in combination with pembrolizumab.
Bibliography:Application Number: US202418440775